Prophase Labs Inc (PRPH) 1.83 $PRPH ProPhase Labs

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prophase Labs Inc (PRPH) 1.83 $PRPH

ProPhase Labs Reports Financial Results for the Three Months and Six Months Ended June 30, 2016; Exploring Strategic Alternatives to Enhance Shareholder Value
Marketwire Canada - Tue Aug 09, 5:15PM CDT
DOYLESTOWN, PA--(Marketwired - August 09, 2016) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $2.8 million for the three months ended June 30, 2016 as compared to net sales of $2.2 million for the three months ended June 30, 2015. The Company incurred a net loss for the three months ended June 30, 2016, of $1.1 million, or ($0.06) per share, compared to a net loss of $1.6 million, or ($0.10) per share, for the three months ended June 30, 2015.
PRPH: 1.83 (+0.04)

ProPhase Labs to Release Second Quarter 2016 Results on Tuesday, August 9th
Marketwire Canada - Fri Aug 05, 11:12AM CDT
DOYLESTOWN, PA--(Marketwired - August 05, 2016) - ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the second quarter, ended June 30, 2016, will be released after the market closes on Tuesday, August 9, 2016. A conference call will be held on Wednesday August 10th, at 10:00 am EDT. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and second quarter results. There will be a question and answer session following initial remarks.
PRPH: 1.83 (+0.04)

ProPhase Labs Reports Financial Results for the Three Months Ended March 31, 2016
Marketwired - Tue May 10, 3:10PM CDT
DOYLESTOWN, PA--(Marketwired - May 10, 2016) - ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $5.4 million for the three months ended March 31, 2016 as compared to net sales of $5.9 million for the three months ended March 31, 2015. The Company incurred a net loss for the three months ended March 31, 2016, of $1.3 million, or ($0.08) per share, compared to a net loss of $1.4 million, or ($0.09) per share, for the three months ended March 31, 2015.
PRPH: 1.83 (+0.04)

ProPhase Labs (Nasdaq: PRPH) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Thu Apr 07, 9:00AM CDT
What:
PRPH: 1.83 (+0.04), NDAQ: 71.21 (-0.13)

ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
Marketwired - Tue Mar 29, 8:56AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $8.2 million for the three months ended December 31, 2015, as compared to net sales of $9.0 for the three months ended December 31, 2014. The Company incurred a net loss for the three months ended December 31, 2015 of $1.3 million, or ($0.07) per share, compared to a net loss of $676,000, or ($0.05) per share, for the three months ended December 31, 2014.
PRPH: 1.83 (+0.04)

ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th
Marketwired - Fri Mar 25, 7:00AM CDT
ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the fourth quarter, ended December 31, 2015, will be released before the market opens on Tuesday, March 29, 2016. A conference call will be held later that morning on March 29th, at 11:00am EST. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and fourth quarter results. There will be a question and answer session following initial remarks.
PRPH: 1.83 (+0.04)

ProPhase Labs Discusses the Current Cold Season and Announces Launch of New Product Line, TK Supplements
Marketwired - Wed Jan 13, 5:47PM CST
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today noted that key industry statistics reveal that according to IMS Health, the incidence of upper respiratory illness across the country has been down double digits for the current cold season(1) to date compared to the prior year cold season. For the week ending December 31, 2015, cold and flu related illnesses are down approximately 25% as compared to the week ending December 31, 2014.
PRPH: 1.83 (+0.04)

BUYINS.NET: PRPH SqueezeTrigger Price is $1.48. There is $28,950 That Short Sellers Still Need To Cover.
M2 - Fri Dec 18, 2:35AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring Prophase Labs Inc (NASDAQ RPH) in real time and just received an alert that PRPH is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 19300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $1.48. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
PRPH: 1.83 (+0.04)

BUYINS.NET: PRPH SqueezeTrigger Price is $1.48. There is $23,104 That Short Sellers Still Need To Cover.
M2 - Thu Dec 03, 5:49AM CST
November 30, 2015
PRPH: 1.83 (+0.04)

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2015
Marketwired - Thu Nov 12, 7:01AM CST
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $4.4 million for the three months ended September 30, 2015, as compared to net sales of $5.1 million for the three months ended September 30, 2014. The Company realized net income for the three months ended September 30, 2015 of $602,000, or $0.04 per share, compared to a net loss of $3.2 million, or ($0.18) per share, for the three months ended September 30, 2014.
PRPH: 1.83 (+0.04)

ProPhase Labs, Inc. (Nasdaq RPH) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Thu Sep 17, 10:01AM CDT
What:
PRPH: 1.83 (+0.04), NDAQ: 71.21 (-0.13)

ProPhase Labs incurs lower net loss of USD1.6m for three months ended 30 June 2015
M2 - Thu Aug 13, 3:29AM CDT
Medical science company ProPhase Labs (NASDAQ RPH) disclosed on Wednesday that it recorded a net loss of USD1.6m (USD0.10) per share) for the three months ended 30 June 2015.
PRPH: 1.83 (+0.04)

ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2015
Marketwired - Wed Aug 12, 7:00AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $2.2 million for the three months ended June 30, 2015, as compared to net sales of $1.8 million for the three months ended June 30, 2014. The Company realized a net loss for the three months ended June 30, 2015 of $1.6 million, or ($0.10) per share, compared to a net loss of $3.1 million, or ($0.19) per share, for the three months ended June 30, 2014.
PRPH: 1.83 (+0.04)

BUYINS.NET: PRPH SqueezeTrigger Price is $1.48. There is $34,650 That Short Sellers Still Need To Cover.
M2 - Fri Aug 07, 2:45AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Prophase Labs Inc (NASDAQ RPH) in real time and just received an alert that PRPH is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 22500 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $1.48. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
PRPH: 1.83 (+0.04)

ProPhase Establishes 3.2 Million Share Equity Line
Marketwired - Wed Aug 05, 11:57AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) announced today that as of July 30, 2015, it entered into an Investment Agreement (the "Investment Agreement" with Dutchess Opportunity Fund, II, LP, a Delaware limited partnership ("Dutchess" . Pursuant to the Investment Agreement, Dutchess committed to purchase, subject to certain restrictions and conditions, up to 3,200,000 shares of the Company's common stock, over a period of 36 months from the first trading day following the effectiveness of the registration statement registering the resale of shares purchased by Dutchess pursuant to the Investment Agreement.
PRPH: 1.83 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 385

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 67

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 33

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 44

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 0

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 25

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 38

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 113

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading

Top 5 Most Recently Viewed Articles

Cypherpunk Technologies Boosts Zcash Holdings Significantly Year-Over-Year

Updated Category News Views 108

Cypherpunk Technologies Expands Zcash Accumulation CAMBRIDGE, Mass. — Cypherpunk Technologies Inc. (Nasdaq: CYPH), a company deeply engaged in privacy technology, has recently accelerated its efforts to accumulate Zcash, significantly boosting its treasury holdings. This move reflects their strategic commitment to enhancing their corporate asset portfolio and addressing...

Continue Reading
Insights from Access LIVE: The Future of Beverage Leadership

Updated Category News Views 253

Insights from Access LIVE: The Future of Beverage Leadership Leaders from the nation's largest distributors convened to share their insights on innovation, growth, and the future of the beverage alcohol industry. The session, known as "Wholesaler Power Hour — Market Drivers: Wholesale Leaders Blazing a Path to Success," took place on the LIVE Stage at Access LIVE 2025,...

Continue Reading
Understanding Microsoft's Competitive Edge in the Software Sector

Updated Category News Views 211

Dynamic Insights into Microsoft and Its Competitors In the rapidly evolving business landscape, a thorough examination of companies is vital for investors and enthusiasts alike. This article delves into a detailed comparative analysis of Microsoft (NASDAQ: MSFT) relative to its main competitors within the software industry. By evaluating essential financial metrics,...

Continue Reading
The Transformative Financial Journey of Pan American Silver Stock

Updated Category News Views 154

The Impact of Long-Term Investment in Pan American Silver Investing in stocks is often seen as a journey, and Pan American Silver (NYSE: PAAS) stands as a shining example of how patience can yield extraordinary rewards over the years. Over the last decade, Pan American Silver has surpassed market performance, boasting an annualized return of 22.95%, which is significantly...

Continue Reading
Linc Housing Initiates Construction of 90 Affordable Units

Updated Category News Views 219

Linc Housing Begins Construction on New Affordable Homes In a promising development for families in need, Linc Housing has commenced the construction of three new affordable apartment communities. This initiative will create 90 new homes specifically designed for low-income individuals and families. The timing could not be more critical, as communities grapple with an...

Continue Reading